Influence of GSTP1 Polymorphism on the Clinical Outcomes of Patients With Advanced NSCLC Receiving First-Line Bevacizumab-Based Regimen: A Real-World Retrospective Study

BACKGROUND: This study was to investigate the influence of GSTP1 gene polymorphism on the clinical outcomes of patients with advanced non-small-cell lung cancer (NSCLC) receiving first-line bevacizumab plus chemotherapy regimen. METHODS: A total of 128 patients with advanced NSCLC who were administe...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Fei, Tian, Hanji, Jin, Baoli, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679038/
https://www.ncbi.nlm.nih.gov/pubmed/34924779
http://dx.doi.org/10.1177/11795549211059146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679038/
https://www.ncbi.nlm.nih.gov/pubmed/34924779
http://dx.doi.org/10.1177/11795549211059146

Ejemplares similares